Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season

Written by

Merck Receives Positive EU CHMP Opinion for ENFLONSIA<img src=”https://s.w.org/images/core/emoji/16.0.1/72×72/2122.png” alt=”™” class=”wp-smiley”> (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season – NEWSnet – News… as it used to be